Florian S, Krehl S, Loewinger M, Kipp A, Banning A, Esworthy S, Chu FF, Brigelius-Flohe R
Published research on GPLC documents improvements in peak power output, reduction in exercise-induced free radical production, and increases in nitric oxide metabolites following exercise the nitric oxide enhancement is GPLC's most distinctive contribution to Carnifuel, as none of the other four carnitine forms produce meaningful NO support.
The most commonly reported side effect is injection site discomfort or mild local reactions, which resolve quickly
Sermorelin was previously FDA-approved for diagnosing growth hormone deficiency, but it is no longer marketed for treatment, even though doctors can privately still prescribe it for other unapproved uses
meaning that animal studies have shown some adverse effect or there are no well-controlled studies in humans, but potential benefits may warrant use despite potential risks